ABcann Medicinals
IPS Pharma
About Candy Store (aka. Candy Store RBX)
CSHybridCandy Store RBX, bred by Ethos Genetics, is a hybrid cannabis strain that combines the flavours and traits of Lemon Berry Candy OG and Ethos Cookies #16.
Bred by 
Ethos Genetics
This strain is known for its high potency, featuring a Total Active Cannabinoids (TAC) of over 30%, and its impressive yields, with large, orange-sized buds covered in thick trichomes, making it particularly suitable for extractions.
The plant is a medium-tall grower with strong lateral branching, allowing for a substantial harvest. It thrives both indoors and outdoors, flowering in about 60-63 days. The terpenes profile is notable for its blend of sharp candied berries, thick florals, and a gasoline undertone, giving it a distinctive, sweet aroma and taste . Candy Store RBX is well-regarded among growers for its ease of training and resistance to common issues. It has been praised for its vibrant colours and strong performance in various growing conditions. Available in feminised seed packs, Candy Store RBX offers growers the potential for a high-quality harvest with significant resin production .
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Montu Group Pty Ltd.
We believe cannabis should be easily accessible, reliable, widely understood, and integrated into modern healthcare.
Montu is one of the leading cannabis companies in the world. Our integrated ecosystem streamlines the patient experience from beginning to end while establishing new benchmarks in cannabis care in the UK. We are dedicated to enhancing the lives of millions of people through cannabis therapy.
What we do:
- Our main goal is to eliminate barriers and create an easy-to-use, trustworthy access pathway to high-quality cannabis products within the UK market.
- We are supporting the UK medical community in better understanding the developing medical cannabis industry and its wide array of therapeutic applications.
- To stay on the cutting edge of UK market developments, such as product innovation, regulatory changes, trends, and the most recent research.
- We are operating with a long-term time horizon in the UK market and are dedicated to ensuring that patients receive the finest care possible.
Further National Health-Service Information on